Jhunjhunwala-backed Concord Biotech to hit IPO market
Quadria had invested Rs 475.30 crore in 2016 for the 20% stake. Rare Enterprises holds about 24% stake in Concord Biotech.
IPOs: Sebi mulls option for pre-filing of offer documents
In the consultation paper, Sebi has suggested that an issuer should make a public announcement stating that it has done pre-filing of the offer document with Sebi and exchanges.
Yatra aims to raise Rs 750 crore via Initial Public Offering
The remaining shares will be sold by Pandara Trust. According to the DRHP, the offer for sale portion of the issue will see 8.3% of the current total outstanding shares be sold.
LIC IPO: Government files updated draft papers with Q3 financials
In the run-up to the mega IPO, on February 13, the government had filed the draft red herring prospectus (DRHP) with the regulator giving details of financial results till September.
Glenmark Life Sciences files preliminary papers for IPO with SEBI
The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO.
Parents junk IIT-B's probe report on Darshan Solanki suicide
German bishop resigns, cites responsibility in abuse scandal
FM Nirmala Sitharaman reviews PSBs performance amid stress in US banking system
Vigil intensified in UP border districts after intel alert that Amritpal may flee to Nepal
Popular Malayalam actor Innocent continues to be critical, on ECMO support
World boxing championships: Nitu Ghanghas becomes world champion with 5-0 win